SCHEMBL1757552

SCHEMBL1757552

CC(C(=O)OO)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.66

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.60
POLB P06746 2/20 0.55
ALDH1A1 P00352 3/20 0.54
HTT P42858 3/20 0.54
NPC1 O15118 1/20 0.53
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ALOX15 P16050 1/20 0.50
MAPK1 P28482 1/20 0.50
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5839153 0.86 LMNA (0.60) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL21715039 0.84 LMNA (0.58) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL917955 0.83 ALDH1A1 (0.60) LMNAALDH1A1HTTNPC1MAPT
SCHEMBL31483318 0.83 ALDH1A1 (0.60) LMNAALDH1A1HTTNPC1MAPT
SCHEMBL10588728 0.83 KMT2A (0.53) LMNAALDH1A1MAPTGAAKMT2A
SCHEMBL311575 0.81 LMNA (0.55) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL21715126 0.81 PLA2G1B (0.56) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL312623 0.81 LMNA (0.55) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL10577708 0.81 LMNA (0.68) LMNAPOLBALDH1A1HTTNPC1
SCHEMBL8977751 0.79 LMNA (0.66) LMNAPOLBALDH1A1HTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275630-A1 COSMETIC COMPOSITION COMPRISING AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AND A N-ACYLATED AMINO ACID ESTER L'OREAL (FR) 2009-11-05 US claimed
US-7468387-B2 Crystalline forms of imidoalkanpercarboxylic acids SOLVAY SOLEXIS S.P.A. (IT) 2008-12-23 US claimed
EP-1130014-B1 Process for the purification of imidoalkanpercarboxylic acids SOLVAY SOLEXIS SPA (IT) 2006-06-14 EP claimed
JP-2005538978-A 2005-12-22 JP claimed
US-20050245590-A1 Crystalline forms of imidoalkanpercarboxylic acids SOLVAY SOLEXIS S.P.A (IT) 2005-11-03 US claimed
EP-1523474-A1 CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS Solvay Solexis S.p.A. (IT) 2005-04-20 EP claimed
WO-2004007452-A1 CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS SOLVAY SOLEXIS S.P.A. (IT) 2004-01-22 WO claimed
EP-0848628-B1 PROCESS USING A PERACID COMPOSITION FOR DECONTAMINATING MATERIALS CONTAMINATED WITH TOXIC AGENTS FRANCE ETAT (FR) 2003-04-23 EP claimed
EP-0780374-B1 Process for reducing water and polar impurities in imido-alkanpercarboxylic acids AUSIMONT SPA (IT) 2002-04-03 EP claimed
EP-1130014-A2 Process for the purification of imidoalkanpercarboxylic acids Ausimont S.p.A. (IT) 2001-09-05 EP claimed
US-5703245-A HEATING SUSPENSION OF IMIDO ACIDS TO MELTING, SEPARATION OF ORGANIC PHASE AUSIMONT, S.P.A. (IT) 1997-12-30 US claimed
EP-0780374-A1 Process for reducing water and polar impurities in imido-alkanpercarboxylic acids AUSIMONT S.p.A. (IT) 1997-06-25 EP claimed
EP-0325288-B1 IMIDO-AROMATIC PERCARBOXYLIC ACIDS AUSIMONT S.p.A. (IT) 1993-09-01 EP claimed
EP-0325289-B1 BLEACHING AGENTS COMPRISING IMIDO-AROMATIC PERCARBOXYLIC ACIDS AUSIMONT S.p.A. (IT) 1993-09-01 EP claimed
EP-0325289-A1 Bleaching agents comprising imido-aromatic percarboxylic acids AUSIMONT S.p.A. (IT) 1989-07-26 EP claimed
EP-0325288-A1 Imido-aromatic percarboxylic acids AUSIMONT S.p.A. (IT) 1989-07-26 EP claimed
EP-3725866-B1 CLEANING AGENT AND METHOD FOR GENTLY CLEANING A WASHING MACHINE BSH HAUSGERAETE GMBH (DE) 2024-02-28 EP disclosed
EP-4263779-A1 A LAUNDRY TREATMENT COMPOSITION Unilever IP Holdings B.V. (NL) 2023-10-25 EP disclosed
WO-1990007501-A1 PEROXYCARBOXYLIC ACIDS INTEROX CHEMICALS LIMITED (GB) 1990-07-12 WO disclosed
EP-0325289-A1 Bleaching agents comprising imido-aromatic percarboxylic acids AUSIMONT S.p.A. (IT) 1989-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245590-A1 Crystalline forms of imidoalkanpercarboxylic acids UACA, CA1, SLC25A1 LMNA 1128/4885POLB 1990/4885ALDH1A1 1199/4885
US-20090275630-A1 COSMETIC COMPOSITION COMPRISING AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AND A N-ACYLATED AMINO ACID ESTER DDC, ALAD, AADAC LMNA 3398/4885POLB 3271/4885ALDH1A1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.